Archive for January 21st, 2009

Stock picks from the Value Method (VM1) strategy are being spotlighted today by Zacks, the nation?s largest independent stock research firm. This strategy surged +21.7% during the first half 2008, while the S&P 500 dropped by nearly -12%. In fact, from 2001 through 2007, the strategy has averaged +41.9% yearly.
More: continued here

A Citi analyst bumped medical equipment maker Hologic Inc. from his top stock picks list, citing the pressure a lack of hospital spending will likely place on the company’s shares.
More: continued here

The restructuring at the electronics company is meeting resistance from manufacturing executives, a report says.
More: continued here

Four free stock picks are being made available today on Zacks.com. The industry?s leading independent research firm highlights one Zacks #1 Rank Strong Buy or a Zacks #2 Rank Buy stock for each of the four main styles of investing: Aggressive Growth, Growth & Income, Momentum, and Value.
More: continued here

Asian stocks ended lower Wednesday as the inauguration of a new U.S. president was overshadowed by concerns that rising bank losses will cripple the world economy.
More: continued here

U.S. regulators are examining Apple’s disclosures about CEO Steve Jobs’s health problems to ensure investors weren’t misled, a report says.
More: continued here

CHICAGO—-Stock picks from the Value Method strategy are being spotlighted today by Zacks, the nation?s largest independent stock research firm. This strategy surged +21.7% during the first half 2008, while the S&P 500 dropped by nearly -12%.
More: continued here

The mining company plans to cut its global work force and said it would record an impairment charge of $1.6 billiion to suspend or cut operations at two nickel mines.
More: continued here

Novartis said Wednesday it received approval in Japan to market four drugs to treat asthma, cancer, hypertension and blindness.
More: continued here

The Swedish telecommunications equipment maker plans to cut 5,000 jobs after reporting a 31% decline in fourth-quarter earnings.
More: continued here